HEPATOCELLULAR CARCINOMA, HEPATITIS B AND MEASLES SIR-Primary hepatocellular carcinoma (PHC) is a common malignant tumour of sub-Saharan Africa (Leading article, 1970) . Evidence of hepatitis B infection (either HBs antigenaemia at the time of diagnosis, or the presence of antibody to HBc or HBs) is found significantly more frequently in PCH patients than in controls (Larouze et al., 1976) . Persistence of Hepatitis B may be associated with an inadequate cellular immune response (Dudley et al., 1972) as a result of which chronic hepatitis, cirrhosis and PHC may develop. The transition, however, from an HBvinfected liver through these stages to PHC has not been described in Africa. A biological marker which indicates whether patients with HBs-associated PHC had passed through these stages would be of considerable clinical and epidemiological importance.
Measles is a widespread disease in Africa with a significant morbidity, often occurring at a younger age than in Western countries (Morley 1969) Triger and colleagues. (Triger et (li., 1972) demonstrated the presence of a highly significant increase in high-titre measles and rubella antibodies in patients Awith chronic active hepatitis, but no clinical evidence of recent measles. Laitinen & Vaheri (1974) , in a study of measles and rubella antibodies in the sera of 12,269 patients, found 30 with very high titres, 15 of whom were suffering from acute or chronic liver disease. This present study aimed to see
Nwhether patients with HBs-associated PHC had measles-antibody levels greater than normal controls, as a possible marker of previous chronic liver disease.
Measles-antibody titres in 16 African adults with proved HBs+ PHC were compared with 16 normal African adults wrho were HBs-.
Measles antibody was measured by an enzymelinked immunosorbent assay (ELISA) method; 3 negative controls were also included. At the end of the ELISA reaction, the absorbance of the contents of each well wAas measured sphectrophotometrically at 400 nm, and the results of the 2 groups compared.
There wiere 5 females in the PHC group, and 8 in the controls. The ages of the PHC patients wiere not accurately known, though none was less than about 20 years. The absorbance values for the 2 groups, and the 3 negative controls, are shown in the Figure. The mtean absorbance of the PHC group was 0 62 (s.e. 0.09), compared to 0 75 (s.e. 0.05) for the controls, an insignificant difference. In this study, 4/16 PHC patients had no serological evidence of past measles, and in none of the PHC patients Nere very high levels of antibody detected. Measles-antibody levels cannot therefore be used as a biological marker of preceding chronic hepatitis in the genesis of PHC. It may be that, following resolution of activity in chronic hepatitis, measles-antibody levels return to normal; or, in these African patients, chronic hepatitis is not associated with high measles-antibody levels; or, since cirrhosis may be found in up to 65 % of West African PHC patients (Payet & Sankale, 1971) 
